Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Nobutaka, Iwakuma"'
Autor:
Rie Sugihara, Hidetaka Watanabe, Shuntaro Matsushima, Yuriko Katagiri, Shuko Saku, Mina Okabe, Yuko Takao, Nobutaka Iwakuma, Etsuyo Ogo, Fumihiko Fujita, Uhi Toh
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background The primary tumor resection (PTR) of de novo stage IV breast cancer (DnIV BC) is controversial, and previous studies have suggested that the neutrophil-to-lymphocyte ratio (NLR) could be a poor-prognosis factor for BC. We investig
Externí odkaz:
https://doaj.org/article/da888d77f3f348358e3bf2fc77371236
Publikováno v:
Surgery Today
Advances in multi-modality treatments incorporating systemic chemotherapy, endocrine therapy, and radiotherapy for the management of breast cancer have resulted in a surgical-management paradigm change toward less-aggressive surgery that combines the
Publikováno v:
Clinical Imaging. 53:120-125
Tumors originating from the nipple-areolar complex of the breast are rare. We herein report the case of a patient with metachronous bilateral areolar methotrexate (MTX)-associated lymphoma. The patient was a 67-year-old woman who presented with a rap
Autor:
Kyogo Itoh, Shigeki Shichijo, Nobutaka Iwakuma, Uhi Toh, Akira Yamada, Yoshito Akagi, Yuko Takao, Shuko Saku, Sayaka Sakurai, Mina Okabe
Publikováno v:
Cancer Science
We undertook an early phase II study of mixed 19‐peptide cancer vaccine monotherapy for 14 advanced metastatic triple‐negative breast cancer (mTNBC) patients refractory to systemic chemotherapy to develop a new type of cancer vaccine. The treatme
Autor:
Shino Nakagawa, Yoshito Akagi, Miki Takenaka, Momoko Akashi, Takahiro Shigaki, Nobutaka Iwakuma
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 79:2208-2214
Autor:
Naoko Seki, Etsuyo Ogo, Akihiko Kawahara, Kyogo Itoh, Uhi Toh, Yuko Kimitsuki, Yoshito Akagi, Nobutaka Iwakuma, Momoko Akashi, Mina Okabe, Shuko Saku
Publikováno v:
Cancer Science
The aim of this research was to investigate the correlation of immunologic factors in the tumor environment of breast cancer, using immunohistological staining to evaluate the expression of programmed death 1/programmed death ligand 1 (PD-1/PD-L1), p
Autor:
Ken-ichi Watanabe, Mari S. Oba, Shigehira Saji, Takashi Takeshita, Nobutaka Iwakuma, Norikazu Masuda, Yuichiro Kikawa, Naoki Niikura, Shinji Ohno, Takayuki Iwamoto, Kokoro Kobayashi
Publikováno v:
Cancer Research. 80:OT2-02
Background: Fulvestrant is one of the standard treatments for first- and second-line endocrine therapy for hormone receptor (HR)-positive metastatic breast cancer (MBC). Palbociclib inhibits cyclin dependent kinase (CDK) 4 and CDK6 in vitro, resultin
Autor:
Mai Mishima, Kotaro Yuge, Masayoshi Kage, Teruhiko Fujii, Keisuke Miwa, Uhi Toh, Miki Takenaka, Mototsugu Matsunaga, Hiroki Takahashi, Masaru Fukahori, Tomoyuki Ushijima, Shino Nakagawa, Yoshito Akagi, Nobutaka Iwakuma, Ryuji Takahashi
Publikováno v:
Current Cancer Therapy Reviews. 10:225-233
Autor:
Uhi Toh, Hiroki Takahashi, Momoko Akashi, Yuka Inoue, Shino Nakagawa, Eisuke Fukuma, Ryuji Takahashi, Nobutaka Iwakuma, Kazuo Shirouzu, Miki Takenaka, Teruhiko Fujii
Publikováno v:
Surgery Today. 44:2037-2044
We compared the safety, invasiveness and cosmetic outcomes between endoscopic breast-conserving surgery (endoscopic group) and surgery under direct vision (direct vision group) for treating breast cancer. We compared 100 cases of endoscopic surgery w